AMR Conference 2020

News

JPI AMR dashboard shows public investments in AMR

According to the newly published JPI AMR Research Funding Dashboard, the 22 member countries invested around 1.8bn€ in AMR research in 2017.

An extensive overview of public investments into antimicrobial resistance (AMR) research is now available on the newly published JPIAMR Research Funding Dashboard. This dynamic tool inlcudes funding data until the year 2017 from 22 JPIAMR member countries, the European Commission and the Wellcome Trust. The dashboard enables interactive analyses for exploring data on national competitive grants by agency, country, JPIAMR research priority and individual research projects. It is aimed at serving as a resource for the scientific community, funders, policy makers and others to gain insight into the scale and scope of publicly funded AMR research in member countries of JPIAMR.

The data visualised in the AMR Research Funding Dashboard was collected in the JPIAMR 2017 mapping exercise and is categorised around the JPIAMR Strategic Research Agenda’s (SRA) six priority topics – therapeutics, diagnostics, surveillance, transmission, environment, and interventions. The mapping recorded a total investment of 1794 M€ in AMR research from a total of 1 939 projects. Of the projects reported, 76.2% of the total investment was recorded for research projects in antibiotic resistance followed by 20.6% in anti-parasitic and 3.2% in anti-fungal resistance research. Analyses on total investments in JPIAMR priority areas indicated that a majority of the grants (57.6%) were dedicated to the priority area therapeutics, followed by diagnostics (13.1%), interventions (11.3%), transmission (7.5%), surveillance (6.7%) and environment (3.8%).

The JPIAMR 2017 mapping shows that JPIAMR member countries are continuing to increase funding of AMR as a national priority. Although the majority of funding is still directed towards therapeutics as a solution of combatting AMR, increased investments were also observed for the other priority areas. Nevertheless, investments in research on AMR in the environment at national levels are still low. Further national commitments to support funding for detection and prevention of the spread of AMR in a truly “One Health” framework are needed.

Please visit the JPIAMR website to read more on AMR mapping and to experience the AMR Research Funding Dashboard: https://www.jpiamr.eu/amr-research-funding-dashboard/